Inside First Clinical Trial Testing Malaria Drug as Coronavirus Treatment

April 15  

Via NBC News

The malaria drug hydroxychloroquine is being prescribed to treat coronavirus after it was given an exemption for emergency use by the FDA. Dr. Tim Schacker and his team at the University of Minnesota are leading the first of nine nationwide clinical trials for the drug and are halfway through their study. The drug has sparked a lot of hope, but experts warn there are some possible risks in using it.

Watch the video at NBC News


The Medical Alley Association is providing COVID-19 related information, including the “COVID-19 Resource Connect” feature on its website and summaries of laws, executive orders, and government programs that may be of interest to members, as a public service.   The Medical Alley Association makes no representations, guarantees, or warranties as to the accuracy, completeness, currency, or suitability of the COVID-19 related information provided by the Medical Alley Association on its website, in newsletters, or in any other communications. The Medical Alley Association specifically disclaims any and all liability for any claims or damages that may result from providing COVID-19 related information online or in other communications or linking to third party websites or other sources of information. The Medical Alley Association makes no effort to independently verify, and does not exert editorial control over, information provided by third parties.  

The Medical Alley Association does not endorse any of the products, vendors, consultants, or documentation referenced in, or connected to parties through, the COVID-19 Resource Connect feature or via email or other communications.

Success message!
Warning message!
Error message!